Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.


 



 

 

RASAYANA™ TECHNOLOGY PLATFORM
Rasayana™ is a highly customizable family of drug delivery vehicles that can easily be customized to carry a wide range of therapeutics, MRI contrast agents and targeting agents in the form of Target Specific Delivery Vehicles (TSDV™). 

 

Rasayana™ is a highly customizable family of drug delivery vehicles that can easily be customized to carry a wide range of therapeutics, MRI contrast agents and targeting agents in the form of Target Specific Delivery Vehicles (TSDV™).  TSDV™ uses the customizable nanoparticles with core shell particles called NanoBindi™ that uses BOSH™ polymers as a shell.  BOSH™ polymers are unique in that they can be functionalized for solubility, stability, temperature sensitivity, release on demand, providing unparalleled “functionality” for formulation and delivery of therapeutics.  TSDV™ polymers are not merely passive drug carriers that degrade over time. Through modifications of the four bioreactive groups present on the polymer shell surface, the NanoBindi’s™ are made to respond to biological mechanisms and micro-environmental conditions to trigger the release of appropriate amounts of drug payload at the appropriate time and in the desired location.  Chikujee has also modified the Rasayana™ delivery system to include targeting ligands and confirmed receptor-mediated uptake into specific target cells (both to tumor cells and to cardiovascular plaques) in in vivo animal studies.   

Rasayana™ has the potential to dramatically enhance the therapeutic index of many classes of drugs – from small molecule drugs to large, macromolecular therapeutics such as proteins, and peptides – by significantly improving efficacy, reducing side effects and reducing frequency and time of administration for patients.  Through our understanding of the individual properties of our proprietary TSDV™ and the limitations of drug candidates, we can customize Rasayana™-drug combinations with features that cannot currently be provided by other nanoparticle based small molecule delivery platforms, whether solid gold based, lipid- or polymer-based. 

 

 
home | site index | terms of use | disclaimer | contact us
©2008 Chikujee Therapeutics, Inc. All rights reserved.